| Production of hepatitis B surface antigen in transgenic plants for oral immunization LJ Richter, Y Thanavala, CJ Arntzen, HS Mason Nature biotechnology 18 (11), 1167-1171, 2000 | 711 | 2000 |
| Oral immunization with hepatitis B surface antigen expressed in transgenic plants Q Kong, L Richter, YF Yang, CJ Arntzen, HS Mason, Y Thanavala Proceedings of the National Academy of Sciences 98 (20), 11539-11544, 2001 | 469 | 2001 |
| Immunogenicity in humans of an edible vaccine for hepatitis B Y Thanavala, M Mahoney, S Pal, A Scott, L Richter, N Natarajan, ... Proceedings of the National Academy of Sciences 102 (9), 3378-3382, 2005 | 412 | 2005 |
| Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated … S Kalathil, AA Lugade, A Miller, R Iyer, Y Thanavala Cancer research 73 (8), 2435-2444, 2013 | 276 | 2013 |
| Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses Z Huang, G Elkin, BJ Maloney, N Beuhner, CJ Arntzen, Y Thanavala, ... Vaccine 23 (15), 1851-1858, 2005 | 223 | 2005 |
| Immune dysfunction in patients with chronic obstructive pulmonary disease TA Bhat, L Panzica, SG Kalathil, Y Thanavala Annals of the American Thoracic Society 12 (Supplement 2), S169-S175, 2015 | 206 | 2015 |
| Sorafenib: a clinical and pharmacologic review R Iyer, G Fetterly, A Lugade, Y Thanavala Expert opinion on pharmacotherapy 11 (11), 1943-1955, 2010 | 173 | 2010 |
| An animal model of inhaled vitamin E acetate and EVALI-like lung injury TA Bhat, SG Kalathil, PN Bogner, BC Blount, MIL Goniewicz, ... New England Journal of Medicine 382 (12), 1175-1177, 2020 | 154 | 2020 |
| Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection AA Lugade, PN Bogner, TH Thatcher, PJ Sime, RP Phipps, Y Thanavala The Journal of Immunology 192 (11), 5226-5235, 2014 | 141 | 2014 |
| T-Regulatory Cells and Programmed Death 1+ T Cells Contribute to Effector T-Cell Dysfunction in Patients with Chronic Obstructive Pulmonary Disease SG Kalathil, AA Lugade, V Pradhan, A Miller, GI Parameswaran, S Sethi, ... American journal of respiratory and critical care medicine 190 (1), 40-50, 2014 | 139 | 2014 |
| Idiotypic networks and their possible exploitation for manipulation of the immune response IM Roitt, DK Male, G Guarnotta, LP De Carvalho, A Cooke, FC Hay, ... The Lancet 317 (8228), 1041-1045, 1981 | 114 | 1981 |
| High‐yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system Z Huang, K LePore, G Elkin, Y Thanavala, HS Mason Plant biotechnology journal 6 (2), 202-209, 2008 | 97 | 2008 |
| Lymphocyte Proliferative Response to P6 ofHaemophilus influenzae Is Associated with Relative Protection from Exacerbations of Chronic Obstructive Pulmonary … Y Abe, TF Murphy, S Sethi, HS Faden, J Dmochowski, Y Harabuchi, ... American journal of respiratory and critical care medicine 165 (7), 967-971, 2002 | 97 | 2002 |
| Novel nanoparticles for the delivery of recombinant hepatitis B vaccine DJ Bharali, V Pradhan, G Elkin, W Qi, A Hutson, SA Mousa, Y Thanavala Nanomedicine: Nanotechnology, Biology and Medicine 4 (4), 311-317, 2008 | 73 | 2008 |
| Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention A Visweswaraiah, LA Novotny, EJ Hjemdahl-Monsen, LO Bakaletz, ... Vaccine 20 (25-26), 3209-3220, 2002 | 70 | 2002 |
| Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide. MW Pride, H Shi, JM Anchin, DS Linthicum, PT LoVerde, A Thakur, ... Proceedings of the National Academy of Sciences 89 (24), 11900-11904, 1992 | 68 | 1992 |
| Secondhand smoke induces inflammation and impairs immunity to respiratory infections TA Bhat, SG Kalathil, PN Bogner, A Miller, PV Lehmann, TH Thatcher, ... The Journal of Immunology 200 (8), 2927-2940, 2018 | 67 | 2018 |
| Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy SG Kalathil, A Hutson, J Barbi, R Iyer, Y Thanavala JCI insight 4 (15), 2019 | 66 | 2019 |
| High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy SG Kalathil, Y Thanavala Cancer Immunology, Immunotherapy 65, 813-819, 2016 | 65 | 2016 |
| PD-1+ and Foxp3+ T cell reduction correlates with survival of HCC patients after sorafenib therapy SG Kalathil, AA Lugade, A Miller, R Iyer, Y Thanavala JCI insight 1 (11), 2016 | 63 | 2016 |
